Copner Biotech

Copner Biotech Ltd was founded in 2020 with the vision to disrupt the 3D cell culture market with innovative technologies. The 3D cell culture space has the potential to further important medical research with real world benefits, such as cancer research and tissue engineering. Copner Biotech’s goal is to design, create and utilise new software platforms to manufacture competitive products for the 3D cell culture market.